{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:47:17Z","timestamp":1778874437325,"version":"3.51.4"},"reference-count":68,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"9","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["award335024"],"award-info":[{"award-number":["award335024"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["39284 and OPP1054324"],"award-info":[{"award-number":["39284 and OPP1054324"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>\n            Screening of 10,000 compounds reveals anti-\n            <jats:italic>Wolbachia<\/jats:italic>\n            chemotypes with potential to be developed into new drugs for two NTDs.\n          <\/jats:p>","DOI":"10.1126\/sciadv.aao1551","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T01:00:22Z","timestamp":1506560422000},"source":"Crossref","is-referenced-by-count":26,"title":["Identification and prioritization of novel anti-\n            <i>Wolbachia<\/i>\n            chemotypes from screening a 10,000-compound diversity library"],"prefix":"10.1126","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5861-2646","authenticated-orcid":false,"given":"Kelly L.","family":"Johnston","sequence":"first","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren A. N.","family":"Cook","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-0738","authenticated-orcid":false,"given":"Neil G.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"David Hong","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-0530","authenticated-orcid":false,"given":"Rachel H.","family":"Clare","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Goddard","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-2866","authenticated-orcid":false,"given":"Louise","family":"Ford","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9730-0960","authenticated-orcid":false,"given":"Gemma L.","family":"Nixon","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-3192","authenticated-orcid":false,"given":"Stephen A.","family":"Ward","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-9275","authenticated-orcid":false,"given":"Mark J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"201617","DOI":"10.1155\/2011\/201617","article-title":"Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline","volume":"2011","author":"Debrah A. Y.","year":"2011","unstructured":"A. Y. Debrah, S. Mand, Y. Marfo-Debrekyei, L. Batsa, A. Albers, S. Specht, U. Klarmann, K. Pfarr, O. Adjei, A. Hoerauf, Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline. J. Parasitol. Res. 2011, 201617 (2011).","journal-title":"J. Parasitol. Res."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01949.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1371\/journal.ppat.0020092","article-title":"Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis","volume":"2","author":"Debrah A. Y.","year":"2006","unstructured":"A. Y. Debrah, S. Mand, S. Specht, Y. Marfo-Debrekyei, L. Batsa, K. Pfarr, J. Larbi, B. Lawson, M. Taylor, O. Adjei, A. Hoerauf, Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis. PLOS Pathog. 2, e92 (2006).","journal-title":"PLOS Pathog."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.actatropica.2012.10.011","article-title":"A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India","volume":"125","author":"Gayen P.","year":"2013","unstructured":"P. Gayen, A. Nayak, P. Saini, N. Mukherjee, S. Maitra, P. Sarkar, S. P. Sinha Babu, A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India. Acta Trop. 125, 150\u2013156 (2013).","journal-title":"Acta Trop."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.2009.09-0155","article-title":"Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine","volume":"81","author":"Mand S.","year":"2009","unstructured":"S. Mand, K. Pfarr, P. K. Sahoo, A. K. Satapathy, S. Specht, U. Klarmann, A. Y. Debrah, B. Ravindran, A. Hoerauf, Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am. J. Trop. Med. Hyg. 81, 702\u2013711 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/586753","article-title":"Doxycycline treatment of Brugia malayi\u2014infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment","volume":"46","author":"Supali T.","year":"2008","unstructured":"T. Supali, Y. Djuardi, K. M. Pfarr, H. Wibowo, M. J. Taylor, A. Hoerauf, J. J. Houwing-Duistermaat, M. Yazdanbakhsh, E. Sartono, Doxycycline treatment of Brugia malayi\u2014infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Clin. Infect. Dis. 46, 1385\u20131393 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66591-9"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/cid\/civ363","article-title":"Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: A randomized, placebo-controlled, double-blind trial","volume":"61","author":"Debrah A. Y.","year":"2015","unstructured":"A. Y. Debrah, S. Specht, U. Klarmann-Schulz, L. Batsa, S. Mand, Y. Marfo-Debrekyei, R. Fimmers, B. Dubben, A. Kwarteng, M. Osei-Atweneboana, D. Boakye, A. Ricchiuto, M. B\u00fcttner, O. Adjei, C. D. Mackenzie, A. Hoerauf, Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: A randomized, placebo-controlled, double-blind trial. Clin. Infect. Dis. 61, 517\u2013526 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-007-0062-1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00436-008-1217-8","article-title":"Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus","volume":"104","author":"Hoerauf A.","year":"2009","unstructured":"A. Hoerauf, S. Specht, Y. Marfo-Debrekyei, M. B\u00fcttner, A. Y. Debrah, S. Mand, L. Batsa, N. Brattig, P. Konadu, C. Bandi, R. Fimmers, O. Adjei, D. W. B\u00fcttner, Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol. Res. 104, 437\u2013447 (2009).","journal-title":"Parasitol. Res."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000660"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40249-016-0160-7","article-title":"Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: Epidemiological evaluation results","volume":"5","author":"Tekle A. H.","year":"2016","unstructured":"A. H. Tekle, H. G. Zour\u00e9, M. Noma, M. Boussinesq, L. E. Coffeng, W. A. Stolk, J. H. F Remme, Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: Epidemiological evaluation results. Infect. Dis. Poverty 5, 66 (2016).","journal-title":"Infect. Dis. Poverty"},{"key":"e_1_3_2_14_2","first-page":"489","article-title":"489 Global programme to eliminate lymphatic filariasis: Progress report, 2014","volume":"90","author":"WHO","year":"2015","unstructured":"WHO, 489 Global programme to eliminate lymphatic filariasis: Progress report, 2014. Wkly. Epidemiol. Rec. 90, 489\u2013504 (2015).","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QCO.0b013e32833fdee5","article-title":"Elimination of lymphatic filariasis: Do we have the drugs to complete the job?","volume":"23","author":"Bockarie M. J.","year":"2010","unstructured":"M. J. Bockarie, R. M. Deb, Elimination of lymphatic filariasis: Do we have the drugs to complete the job? Curr. Opin. Infect. Dis. 23, 617\u2013620 (2010).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pt.2011.10.003","article-title":"Elimination of onchocerciasis from Africa: Possible?","volume":"28","author":"Mackenzie C. D.","year":"2012","unstructured":"C. D. Mackenzie, M. M. Homeida, A. D. Hopkins, J. C. Lawrence, Elimination of onchocerciasis from Africa: Possible? Trends Parasitol. 28, 16\u201322 (2012).","journal-title":"Trends Parasitol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-308X(05)60004-8","article-title":"Wolbachia bacterial endosymbionts of filarial nematodes","volume":"60","author":"Taylor M. J.","year":"2005","unstructured":"M. J. Taylor, C. Bandi, A. Hoerauf, Wolbachia bacterial endosymbionts of filarial nematodes. Adv. Parasitol. 60, 245\u2013284 (2005).","journal-title":"Adv. Parasitol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60586-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1087057113511270","article-title":"Overcoming the challenges of drug discovery for neglected tropical diseases: The A WOL experience","volume":"19","author":"Johnston K. L.","year":"2014","unstructured":"K. L. Johnston, L. Ford, M. J. Taylor, Overcoming the challenges of drug discovery for neglected tropical diseases: The A WOL experience. J. Biomol. Screen. 19, 335\u2013343 (2014).","journal-title":"J. Biomol. Screen."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182013001108"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.09.001"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.2174\/13816128113199990602","article-title":"Strategies for small molecule library design","volume":"20","author":"Sheppard D. W.","year":"2014","unstructured":"D. W. Sheppard, M. J. Lipkin, C. J. Harris, C. Catana, P. F. W. Stouten, Strategies for small molecule library design. Curr. Pharm. Des. 20, 3314\u20133322 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1021\/jm201108k","article-title":"Novel orally active antimalarial thiazoles","volume":"54","author":"Gonz\u00e1lez Cabrera D.","year":"2011","unstructured":"D. Gonz\u00e1lez Cabrera, F. Douelle, T. S. Feng, A. T. Nchinda, Y. Younis, K. L. White, Q. Wu, E. Ryan, J. N. Burrows, D. Waterson, M. J. Witty, S. Wittlin, S. A. Charman, K. Chibale, Novel orally active antimalarial thiazoles. J. Med. Chem. 54, 7713\u20137719 (2011).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/jm401760c","article-title":"2,4-Diaminothienopyrimidines as orally active antimalarial agents","volume":"57","author":"Gonz\u00e1lez Cabrera D.","year":"2014","unstructured":"D. Gonz\u00e1lez Cabrera, C. Le Manach, F. Douelle, Y. Younis, T.-S. Feng, T. Paquet, A. T. Nchinda, L. J. Street, D. Taylor, C. de Kock, L. Wiesner, S. Duffy, K. L. White, K. M. Zabiulla, Y. Sambandan, S. Bashyam, D. Waterson, M. J. Witty, S. A. Charman, V. M. Avery, S. Wittlin, K. Chibale, 2,4-Diaminothienopyrimidines as orally active antimalarial agents. J. Med. Chem. 57, 1014\u20131022 (2014).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jm500098s","article-title":"Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: Part 1","volume":"57","author":"Le Manach C.","year":"2014","unstructured":"C. Le Manach, D. Gonz\u00e0lez Cabrera, F. Douelle, A. T. Nchinda, Y. Younis, D. Taylor, L. Wiesner, K. L. White, E. Ryan, C. March, S. Duffy, V. M. Avery, D. Waterson, M. J. Witty, S. Wittlin, S. A. Charman, L. J. Street, K. Chibale, Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: Part 1. J. Med. Chem. 57, 2789\u20132798 (2014).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1021\/jm500887k","article-title":"Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: Part 2","volume":"57","author":"Le Manach C.","year":"2014","unstructured":"C. Le Manach, T. Paquet, D. Gonz\u00e0lez Cabrera, Y. Younis, D. Taylor, L. Wiesner, N. Lawrence, S. Schwager, D. Waterson, M. J. Witty, S. Wittlin, L. J. Street, K. Chibale, Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: Part 2. J. Med. Chem. 57, 8839\u20138848 (2014).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4155\/fmc.12.176","article-title":"Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus\u00ae library","volume":"4","author":"Paquet T.","year":"2012","unstructured":"T. Paquet, R. Gordon, D. Waterson, M. J. Witty, K. Chibale, Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus\u00ae library. Future Med. Chem. 4, 2265\u20132277 (2012).","journal-title":"Future Med. Chem."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm3001373"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1021\/jm400279y","article-title":"Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: Hits from SoftFocus kinase and other libraries","volume":"56","author":"Younis Y.","year":"2013","unstructured":"Y. Younis, L. J. Street, D. Waterson, M. J. Witty, K. Chibale, Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: Hits from SoftFocus kinase and other libraries. J. Med. Chem. 56, 7750\u20137754 (2013).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1016\/j.bmc.2015.10.021","article-title":"Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization","volume":"23","author":"Soares de Melo C.","year":"2015","unstructured":"C. Soares de Melo, T.-S. Feng, R. van der Westhuyzen, R. K. Gessner, L. J. Street, G. L. Morgans, D. F. Warner, A. Moosa, K. Naran, N. Lawrence, H. I. Boshoff, C. E. Barry III, C. J. Harris, R. Gordon, K. Chibale, Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization. Bioorg. Med. Chem. 23, 7240\u20137250 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"e_1_3_2_31_2","first-page":"375","article-title":"Chemoinformatics: What is it and how does it impact drug discovery","volume":"33","author":"Brown F. K.","year":"1998","unstructured":"F. K. Brown, Chemoinformatics: What is it and how does it impact drug discovery. Annu. Rep. Med. Chem. 33, 375\u2013384 (1998).","journal-title":"Annu. Rep. Med. Chem."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500588j"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"P. G. Nell S. M. Mundt in High-Throughput Screening in Drug Discovery J. Huser Ed. (Wiley-VCH 2006) vol. 35 chap. 8 pp. 207\u2013257.","DOI":"10.1002\/9783527609321.ch8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/ml200135p","article-title":"An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS","volume":"2","author":"Calder\u00f3n F.","year":"2011","unstructured":"F. Calder\u00f3n, D. Barros, J. M. Bueno, J. M. Coter\u00f3n, E. Fern\u00e1ndez, F. J. Gamo, J. L. Lavandera, M. L. Le\u00f3n, S. J. F. Macdonald, A. Mallo, P. Manzano, E. Porras, J. M. Fiandor, J. Castro, An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS. ACS Med. Chem. Lett. 2, 741\u2013746 (2011).","journal-title":"ACS Med. Chem. Lett."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/17460441.2014.913565","article-title":"Advances in multiparameter optimization methods for de novo drug design","volume":"9","author":"Segall M.","year":"2014","unstructured":"M. Segall, Advances in multiparameter optimization methods for de novo drug design. Expert Opin. Drug Discov. 9, 803\u2013817 (2014).","journal-title":"Expert Opin. Drug Discov."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1517\/17460441.2011.588696","article-title":"Strategies of multi-objective optimization in drug discovery and development","volume":"6","author":"Nicolotti O.","year":"2011","unstructured":"O. Nicolotti, I. Giangreco, A. Introcaso, F. Leonetti, A. Stefanachi, A. Carotti, Strategies of multi-objective optimization in drug discovery and development. Expert Opin. Drug Discov. 6, 871\u2013884 (2011).","journal-title":"Expert Opin. Drug Discov."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrd1156","article-title":"Drug research: Myths, hype and reality","volume":"2","author":"Kubinyi H.","year":"2003","unstructured":"H. Kubinyi, Drug research: Myths, hype and reality. Nat. Rev. Drug Discov. 2, 665\u2013668 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057114551518"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/eri.11.76","article-title":"Progress and challenges in the discovery of macrofilaricidal drugs","volume":"9","author":"Geary T. G.","year":"2011","unstructured":"T. G. Geary, C. D. Mackenzie, Progress and challenges in the discovery of macrofilaricidal drugs. Expert Rev. Anti Infect. Ther. 9, 681\u2013695 (2011).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41598-017-00322-5","article-title":"Short-course, high-dose rifampicin achieves Wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis","volume":"7","author":"Aljayyoussi G.","year":"2017","unstructured":"G. Aljayyoussi, H. E. Tyrer, L. Ford, H. Sjoberg, N. Pionnier, D. Waterhouse, J. Davies, J. Gamble, H. Metugene, D. A. N. Cook, A. Steven, R. Sharma, A. F. Guimaraes, R. H. Clare, A. Cassidy, K. L. Johnston, L. Myhill, L. Hayward, S. Wanji, J. D. Turner, M. J. Taylor, S. A. Ward, Short-course, high-dose rifampicin achieves Wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis. Sci. Rep. 7, 210 (2017).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005156"},{"key":"e_1_3_2_42_2","unstructured":"Y. Lai J. Liang S. R. Magnuson K. D. Robarge V. H. W. Tsui B. Zhang Patent WO2013041539 A1 (2013)."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1021\/jm401395s","article-title":"Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1)","volume":"56","author":"Naud S.","year":"2013","unstructured":"S. Naud, I. M. Westwood, A. Faisal, P. Sheldrake, V. Bavetsias, B. Atrash, K.-M. J. Cheung, M. Liu, A. Hayes, J. Schmitt, A. Wood, V. Choi, K. Boxall, G. Mak, M. Gurden, M. Valenti, A. de Haven Brandon, A. Henley, R. Baker, C. McAndrew, B. Matijssen, R. Burke, S. Hoelder, S. A. Eccles, F. I. Raynaud, S. Linardopoulos, R. L. M. van Montfort, J. Blagg, Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J. Med. Chem. 56, 10045\u201310065 (2013).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/acs.jmedchem.7b00357","article-title":"Design, synthesis, and biological evaluation of dimorpholine substituted thienopyrimidines as potential class I PI3K\/mTOR dual inhibitors","volume":"60","author":"Zhan M.","year":"2017","unstructured":"M. Zhan, Y. Deng, L. Zhao, G. Yan, F. Wang, Y. Tian, L. Zhang, H. Jiang, Y. Chen, Design, synthesis, and biological evaluation of dimorpholine substituted thienopyrimidines as potential class I PI3K\/mTOR dual inhibitors. J. Med. Chem. 60, 4023\u20134035 (2017).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_45_2","unstructured":"S. T. P. C. L. Hinuma M. T. P. C. L. Hirohashi Y. T. P. C. L. Ishichi F. T. P. L. Itoh N. T. C. L. Kanzaki Y. T. P. C. L. Kawamata T. T. P. C. L. Miki S. T. P. C. L. Oi T. T. P. C. L. Tawaraishi Patent EP1591120 A1 (2005)."},{"key":"e_1_3_2_46_2","unstructured":"A. Ullrich M. Falcenberg Patent WO2014207260 (2014)."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acs.jmedchem.5b01156","article-title":"Structure\u2013activity relationship studies of orally active antimalarial 2,4-diamino-thienopyrimidines","volume":"58","author":"Gonz\u00e0lez Cabrera D.","year":"2015","unstructured":"D. Gonz\u00e0lez Cabrera, F. Douelle, C. Le Manach, Z. Han, T. Paquet, D. Taylor, M. Njoroge, N. Lawrence, L. Wiesner, D. Waterson, M. J. Witty, S. Wittlin, L. J. Street, K. Chibale, Structure\u2013activity relationship studies of orally active antimalarial 2,4-diamino-thienopyrimidines. J. Med. Chem. 58, 7572\u20137579 (2015).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.bjp.0705332","article-title":"Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro","volume":"139","author":"Nishimoto T.","year":"2003","unstructured":"T. Nishimoto, Y. Amano, R. Tozawa, E. Ishikawa, Y. Imura, H. Yukimasa, Y. Sugiyama, Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. Br. J. Pharmacol. 139, 911\u2013918 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe K.","year":"2013","unstructured":"K. Pethe, P. Bifani, J. Jang, S. Kang, S. Park, S. Ahn, J. Jiricek, J. Jung, H. K. Jeon, J. Cechetto, T. Christophe, H. Lee, M. Kempf, M. Jackson, A. J. Lenaerts, H. Pham, V. Jones, M. J. Seo, Y. M. Kim, M. Seo, J. J. Seo, D. Park, Y. Ko, I. Choi, R. Kim, S. Y. Kim, S. Lim, S.-A. Yim, J. Nam, H. Kang, H. Kwon, C.-T. Oh, Y. Cho, Y. Jang, J. Kim, A. Chua, B. H. Tan, M. B. Nanjundappa, S. P. S. Rao, W. S. Barnes, R. Wintjens, J. R. Walker, S. Alonso, S. Lee, J. Kim, S. Oh, T. Oh, U. Nehrbass, S.-J. Han, Z. No, J. Lee, P. Brodin, S.-N. Cho, K. Nam, J. Kim, Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat. Med. 19, 1157\u20131160 (2013).","journal-title":"Nat. Med."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200428"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09107"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.177.2.1240","article-title":"Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88\/TLR2-dependent manner","volume":"177","author":"Turner J. D.","year":"2006","unstructured":"J. D. Turner, R. S. Langley, K. L. Johnston, G. Egerton, S. Wanji, M. J. Taylor, Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88\/TLR2-dependent manner. J. Immunol. 177, 1240\u20131249 (2006).","journal-title":"J. Immunol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1756-3305-3-99","article-title":"Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes","volume":"3","author":"Johnston K. L.","year":"2010","unstructured":"K. L. Johnston, B. Wu, A. Guimar\u00e3es, L. Ford, B. E. Slatko, M. J. Taylor, Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes. Parasit. Vectors 3, 99 (2010).","journal-title":"Parasit. Vectors"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.50.3.922-927.2006","article-title":"Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal","volume":"50","author":"Makepeace B. L.","year":"2006","unstructured":"B. L. Makepeace, L. Rodgers, A. J. Trees, Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal. Antimicrob. Agents Chemother. 50, 922\u2013927 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"},{"key":"e_1_3_2_56_2","unstructured":"For information on StarDrop see www.optibrium.com\/stardrop\/stardrop-features.php."},{"key":"e_1_3_2_57_2","unstructured":"For information on BIOVIA Pipeline Pilot see http:\/\/accelrys.com\/products\/collaborative-science\/biovia-pipeline-pilot\/."},{"key":"e_1_3_2_58_2","unstructured":"C. A. James D. Weininger in Daylight Theory Manual 4.34 Daylight CIS Inc. Ed. (1994) chap. 5 pp. 32\u201339."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm901137j"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1020829519597","article-title":"Filtering databases and chemical libraries","volume":"16","author":"Charifson P. S.","year":"2002","unstructured":"P. S. Charifson, W. P. Walters, Filtering databases and chemical libraries. J. Comput. Aided Mol. Des. 16, 311\u2013323 (2002).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/ci990423o","article-title":"Strategic pooling of compounds for high-throughput screening","volume":"39","author":"Hann M.","year":"1999","unstructured":"M. Hann, B. Hudson, X. Lewell, R. Lifely, L. Miller, N. Ramsden, Strategic pooling of compounds for high-throughput screening. J. Chem. Inf. Comput. Sci 39, 897\u2013902 (1999).","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"e_1_3_2_62_2","unstructured":"https:\/\/docs.eyesopen.com\/omega\/filter_files.html."},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.10041","article-title":"Selection criteria for drug-like compounds","volume":"23","author":"Muegge I.","year":"2003","unstructured":"I. Muegge, Selection criteria for drug-like compounds. Med. Res. Rev. 23, 302\u2013321 (2003).","journal-title":"Med. Res. Rev."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008130001697"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1359-6446(97)01083-0","article-title":"Reactive compounds and in vitro false positives in HTS","volume":"2","author":"Rishton G. M.","year":"1997","unstructured":"G. M. Rishton, Reactive compounds and in vitro false positives in HTS. Drug Discov. Today 2, 382\u2013384 (1997).","journal-title":"Drug Discov. Today"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","unstructured":"E. H. Kerns J. Li in Drug-like Properties: Concepts Structure Design and Methods (Elsevier 2008) chap. 15 pp. 197\u2013208.","DOI":"10.1016\/B978-012369520-8.50016-4"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","unstructured":"E. H. Kerns L. Di in Drug-like Properties: Concepts Structure Design and Methods (Elsevier 2008) chap. 9 pp. 103\u2013121.","DOI":"10.1016\/B978-012369520-8.50010-3"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","unstructured":"E. H. Kerns J. Li in Drug-like Properties: Concepts Structure Design and Methods (Elsevier 2008) chap. 16 pp. 209\u2013214.","DOI":"10.1016\/B978-012369520-8.50017-6"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.drudis.2010.04.003","article-title":"Evolving molecules using multi-objective optimization: Applying to ADME\/Tox","volume":"15","author":"Ekins S.","year":"2010","unstructured":"S. Ekins, J. D. Honeycutt, J. T. Metz, Evolving molecules using multi-objective optimization: Applying to ADME\/Tox. Drug Discov. Today 15, 451\u2013460 (2010).","journal-title":"Drug Discov. Today"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aao1551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:43:31Z","timestamp":1704822211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aao1551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1126\/sciadv.aao1551"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aao1551","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]},"article-number":"eaao1551"}}